Yes Growth but also notice the following: Teva (Israel) makes the generic version Doneprizil (Pfizer makes the brand Aricept) ... These are the two strategic potential buyers (Teva and Pfizer) .... and competition is very good when selling something... AVXL has contacts with Israel pharma already with Dr. Abraham Fisher on the AVXL SAB and who led development of Anavex 371 in Israel.. I expect these two companies will be the front runners to buy or partner with AVXL--- ON PAPER.... "On paper" because, there are many many pharma companies that both move very fast (faster than Pfizer and Teva) , trust their own internal analysis (i.e. do not need wall street confirmation) and have the funding in place.. and many in this last category are from outside of here in America.....Japan has about 5 companies alone meeting these parameters and Japan also has the most severe aging demographic. Example is Otsuka Holdings buying Avanir this year for 3.5 Billion (a partial Sigma 1 receptor co) .... Then you have the likes of US companies like Gilead, Celgene, etc adding likely another 10 USA companies capable and in this fast moving side from US ....Then another 10 from Europe also in this fast moving group, not to mention the contacts AVXL already has with several European pharma companies through its SAB and direct dealings....So summing up, I see two front runners (who stand the most to gain through synergy) and then globally and from US, about 25 additional fast mover pharma cos who will be looking under the hood of AVXL... To my thinking it is a toss up if a deal will go with one of the two front runners or the 25 or so other companies who will be considering AVXL...Remember competition is very very good for shareholders of AVXL...
Also, do not fall for the soft bashing here and other MB;s that the results are "not good" .....the results are fantastic....in fact almost anything better than the SOC is fantastic...and do not get boggled down in seemingly sincere posters who throw out negative labels describing results with phrases like "not good"... Remember they are still trying for a "wash out" Monday and following days...I do not care either way much (except hate to see innocent retail raped by crooks with no morals) , but think without manipulation the price would triple Monday...With manipulation I am not sure in the short term, but in the longer term fair value will richly reward...GLTA retail and pros with morals...
